1997
DOI: 10.3109/02841869709001292
|View full text |Cite
|
Sign up to set email alerts
|

Tissue Polypeptide-Specific Antigen (TPS) as Tumour Marker in Epithelial Ovarian Cancer

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2000
2000
2011
2011

Publication Types

Select...
5

Relationship

0
5

Authors

Journals

citations
Cited by 5 publications
(1 citation statement)
references
References 5 publications
0
1
0
Order By: Relevance
“…More recently, some biomarkers from the field of oncology have been tested in HF 3–5. As such, CA‐125, CA 15–3, CA 19–9, carcinoembryonic antigen, alpha‐feto protein, tissue polypeptide antigen (TPA), tissue polypeptide‐specific antigen (TPS),6 cytokeratin 19 fragment (CYFRA 21–1),7 and chromogranin A and B,8 which have been used as tumour markers in various different pathologies, have all been tested in HF studies 3,9,10…”
Section: Introductionmentioning
confidence: 99%
“…More recently, some biomarkers from the field of oncology have been tested in HF 3–5. As such, CA‐125, CA 15–3, CA 19–9, carcinoembryonic antigen, alpha‐feto protein, tissue polypeptide antigen (TPA), tissue polypeptide‐specific antigen (TPS),6 cytokeratin 19 fragment (CYFRA 21–1),7 and chromogranin A and B,8 which have been used as tumour markers in various different pathologies, have all been tested in HF studies 3,9,10…”
Section: Introductionmentioning
confidence: 99%